Autologous or allogeneic hematopoietic cell transplantation for non-Hodgkin's lymphoma?

被引：0
作者：
Blume, KG [1 ]
机构：
[1] Stanford Univ, Div Bone Marrow Transplantat, Sch Med, Stanford, CA 94305 USA
来源：
ANNALS OF HEMATOLOGY | 2002年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S9 / S11
页数：3
相关论文
共 12 条
[1]   TREATMENT OF MALIGNANT-LYMPHOMA IN 100 PATIENTS WITH CHEMOTHERAPY, TOTAL-BODY IRRADIATION, AND MARROW TRANSPLANTATION [J].
APPELBAUM, FR ;
SULLIVAN, KM ;
BUCKNER, CD ;
CLIFT, RA ;
DEEG, HJ ;
FEFER, A ;
HILL, R ;
MORTIMER, J ;
NEIMAN, PE ;
SANDERS, JE ;
SINGER, J ;
STEWART, P ;
STORB, R ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) :1340-1347
[2]  
APPELBAUM FR, 1978, BLOOD, V52, P85
[3]   Improve the outcome of autologous hematopoietic cell transplantation! [J].
Blume, KG .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (10) :527-531
[4]  
CHAMPLIN R, 1999, HAMATOPOIETIC CELL T, P892
[5]   COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].
FISHER, RI ;
GAYNOR, ER ;
DAHLBERG, S ;
OKEN, MM ;
GROGAN, TM ;
MIZE, EM ;
GLICK, JH ;
COLTMAN, CA ;
MILLER, TP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006
[6]   High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma [J].
Gianni, AM ;
Bregni, M ;
Siena, S ;
Brambilla, C ;
DiNicola, M ;
Lombardi, F ;
Gandola, L ;
Tarella, C ;
Pileri, A ;
Ravagnani, F ;
Valagussa, P ;
Bonadonna, G ;
Stern, AC ;
Magni, M ;
Caracciolo, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1290-1297
[7]   High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma [J].
Gopal, AK ;
Rajendran, JG ;
Petersdorf, SH ;
Maloney, DG ;
Eary, JF ;
Wood, BL ;
Gooley, TA ;
Bush, SA ;
Durack, LD ;
Martin, PJ ;
Matthews, DC ;
Appelbaum, FR ;
Bernstein, ID ;
Press, OW .
BLOOD, 2002, 99 (09) :3158-3162
[8]   High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial [J].
Horning, SJ ;
Negrin, RS ;
Hoppe, RT ;
Rosenberg, SA ;
Chao, NJ ;
Long, GD ;
Brown, BW ;
Blume, KG .
BLOOD, 2001, 97 (02) :404-409
[9]  
Horwitz SM, 2000, BLOOD, V96, p384A
[10]   Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality [J].
Khouri, IF ;
Saliba, RM ;
Giralt, SA ;
Lee, MS ;
Okoroji, GJ ;
Hagemeister, FB ;
Korbling, M ;
Younes, A ;
Ippoliti, C ;
Gajewski, JL ;
McLaughlin, P ;
Anderlini, P ;
Donato, ML ;
Cabanillas, FF ;
Champlin, RE .
BLOOD, 2001, 98 (13) :3595-3599
12